Timing of First Respiratory Virus Detections in Infants: A Community-Based Birth Cohort Study

Mohinder Sarna1,2, Robert S Ware2,3, Stephen B Lambert2

  • 1School of Public Health, University of Queensland, Brisbane.

Insights

Infants experience first human rhinovirus (HRV) detection episodes early, around 2.9 months. Other respiratory virus detections occur later, highlighting the need for timely infant interventions and vaccination strategies.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Virology

Background:

  • Understanding the timing of first virus detection episodes (fVDEs) in infants is crucial for identifying high-risk periods.
  • This knowledge informs the development of targeted preventive strategies, including vaccination schedules.

Purpose of the Study:

  • To describe the age and characteristics of fVDEs in a cohort of infants.
  • To explore factors associated with symptomatic fVDEs in early childhood.

Main Methods:

  • The study utilized the Observational Research in Childhood Infectious Diseases (ORChID) cohort.
  • Infant symptoms were recorded daily, and nasal swabs were collected weekly for polymerase chain reaction testing of 17 respiratory viruses.

Main Results:

  • The median age for fVDEs was 2.9 months for human rhinovirus (HRV), significantly earlier than other viruses (≥13.9 months).
  • Symptomatic episodes occurred in 52% of HRV fVDEs versus 57%-83% for other viruses. Respiratory syncytial virus and human metapneumovirus infections were more severe than HRV.
  • Older age and winter season were linked to symptomatic fVDEs.

Conclusions:

  • Infants may not always exhibit symptoms during their first virus detection episodes.
  • Early HRV detection emphasizes the importance of early-life interventions.
  • Later fVDEs for other viruses coincide with waning maternal vaccine immunity, suggesting a critical window for infant vaccination.
Abstract